Sign up to save your podcasts
Or
Share GAUSS STUDY: New alternative for LDL lowering in patients intolerant to statins
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
GAUSS STUDY: New alternative for LDL lowering in patients intolerant to statins
LOS ANGELES—A more powerful back-up drug for patients intolerant to statins was announced at the American Heart Association 2012 Scientific Sessions. A monoclonal antibody called: AMG 145 against a protein found to regulate LDL receptor activity — the PCSK 9 …
View all episodes
By AudioMedica.comLOS ANGELES—A more powerful back-up drug for patients intolerant to statins was announced at the American Heart Association 2012 Scientific Sessions. A monoclonal antibody called: AMG 145 against a protein found to regulate LDL receptor activity — the PCSK 9 …